We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16.5B
AUM Growth
+$1.75B
Cap. Flow
+$507M
Cap. Flow %
3.07%
Top 10 Hldgs %
21.55%
Holding
964
New
170
Increased
275
Reduced
467
Closed
23

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$36.4M
2
FIS icon
Fidelity National Information Services
FIS
+$36M
3
ALLE icon
Allegion
ALLE
+$31.9M
4
MDT icon
Medtronic
MDT
+$28.1M
5
CVX icon
Chevron
CVX
+$27.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$36.2M
2
UNH icon
UnitedHealth
UNH
+$27.4M
3
CELG
Celgene Corp
CELG
+$25M
4
HES
Hess
HES
+$22M
5
CCI icon
Crown Castle
CCI
+$20.6M

Sector Composition

Rank Sector Weight
1 Technology 18.29%
2 Financials 16.69%
3 Healthcare 13.55%
4 Consumer Discretionary 10.79%
5 Communication Services 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPE icon
351
Hewlett Packard
HPE
$58.8B
$7.45M 0.05%
469,804
-6,259
-1% -$100K
MSCI icon
352
MSCI
MSCI
$42.4B
$7.43M 0.05%
28,771
-173
-0.6% -$42.2K
WAT icon
353
Waters Corp
WAT
$37.3B
$7.42M 0.04%
31,740
+8,212
+35% +$1.81M
BMRN icon
354
BioMarin Pharmaceuticals
BMRN
$11.9B
$7.35M 0.04%
86,895
+23,669
+37% +$1.79M
NTRS icon
355
Northern Trust
NTRS
$21.8B
$7.34M 0.04%
69,069
-794
-1% -$81.3K
ZBH icon
356
Zimmer Biomet
ZBH
$18.8B
$7.32M 0.04%
50,365
-2,327
-4% -$321K
AME icon
357
Ametek
AME
$53.9B
$7.32M 0.04%
73,368
+16,682
+29% +$1.58M
REGN icon
358
Regeneron Pharmaceuticals
REGN
$72.9B
$7.31M 0.04%
19,472
-935
-5% -$315K
INCY icon
359
Incyte
INCY
$25.4B
$7.28M 0.04%
83,326
+20,777
+33% +$1.77M
EVRG icon
360
Evergy
EVRG
$19.4B
$7.23M 0.04%
111,125
+27,154
+32% +$1.73M
CBRE icon
361
CBRE Group
CBRE
$43.3B
$7.21M 0.04%
117,551
-237
-0.2% -$13.1K
ESS icon
362
Essex Property Trust
ESS
$19.1B
$7.18M 0.04%
23,852
-277
-1% -$87.5K
ALC icon
363
Alcon
ALC
$34B
$7.15M 0.04%
126,334
-2,424
-2% -$139K
PBA icon
364
Pembina Pipeline
PBA
$29.3B
$7.12M 0.04%
192,459
+11,879
+7% +$425K
DOC icon
365
Healthpeak Properties
DOC
$15.5B
$7.11M 0.04%
206,406
+1,578
+0.8% +$55.2K
CCL icon
366
Carnival Corporation Ltd
CCL
$38.1B
$7.11M 0.04%
139,868
-243
-0.2% -$10.9K
KEY icon
367
KeyCorp
KEY
$23.8B
$7.09M 0.04%
350,291
-2,788
-0.8% -$52.6K
BBY icon
368
Best Buy
BBY
$19B
$7.03M 0.04%
80,041
-570
-0.7% -$43.6K
GIB icon
369
CGI
GIB
$15.6B
$6.99M 0.04%
83,787
-671
-0.8% -$54K
DLTR icon
370
Dollar Tree
DLTR
$24.8B
$6.96M 0.04%
74,057
+15,278
+26% +$1.6M
DXCM icon
371
DexCom
DXCM
$29B
$6.96M 0.04%
127,212
-184
-0.1% -$8.73K
DGX icon
372
Quest Diagnostics
DGX
$26B
$6.94M 0.04%
64,954
+17,728
+38% +$1.85M
AZO icon
373
AutoZone
AZO
$51.3B
$6.92M 0.04%
5,806
-298
-5% -$344K
RACE icon
374
Ferrari
RACE
$67.8B
$6.91M 0.04%
41,647
-945
-2% -$153K
XYL icon
375
Xylem
XYL
$28.5B
$6.88M 0.04%
87,345
+24,273
+38% +$1.89M

Similar funds

Aviva's Q4 2019 Portfolio in Review

As of Q4 2019, Aviva held 964 positions worth $16.5B, up 12% from $14.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aviva deployed $507M of net new capital in Q4 2019, opening 170 new positions and adding to 275 existing holdings. Its largest new stake was ON Semiconductor: 1,068,449 shares worth $26M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $36.2M trimmed.

  • Aviva's largest Q4 2019 buy was ON Semiconductor: 1,068,449 shares worth $26M.
  • Aviva added most to Alibaba in Q4 2019, an estimated $36.4M increase.
  • Aviva's biggest Q4 2019 reduction was Apple, cutting an estimated $36.2M.
  • Aviva fully exited Celgene Corp in Q4 2019, selling an estimated $25M.
  • Aviva's ten largest holdings make up 22% of its $16.5B portfolio in Q4 2019.
  • Aviva opened 170 new positions and closed 23 in Q4 2019.
  • Aviva's portfolio value rose 12% quarter-over-quarter to $16.5B.

Based on Aviva's 13F filing for Q4 2019, filed 10 Feb 2020.